Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems to support clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers controlled temperature technology products; sample preparation and preservation equipment; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; and research and safety market channel, and biopharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Business Analysis of Thermo Fisher Scientific
The Life Sciences Sector is witnessing a major shakeup, new age business models in the industry are transforming both customers and businesses. Faced with this uncertainity, companies are investing resources to transform their business. An in-depth business analysis is a valuable resource to identify and articulate the need for a business model change. At R&P Research we believe, the starting point for a business analysis is Benchmarking. Business benchmarking can be done at various levels: 1) Industry Benchmarking 2) Peer Benchmarking 3) Disruptors Benchmarking. In this report, we share the snapshot of how Thermo Fisher Scientific compares against the industry on the major performance indicators. This analysis, along with peer group/disruptors benchmarking and revenue model understanding can help identify growth and cost optimization opportunities to maximize the value delivered by Thermo Fisher Scientific to its stakeholders. R&P Research Industry Intelligence Platform provides historical data for last 15 years with an easy to use benchmarking interface for an in-depth comparative business analysis.
Here is the performance snapshot of Thermo Fisher Scientific with an interactive chart.
- Revenue Growth: Thermo Fisher Scientific reported a revenue growth of 7.7% year-on-year during 2016. Diagnostics & Scientific Instruments Industry grew at 6.8% in the same period
- COGS share of Revenues: As a percentage of revenue, Thermo Fisher Scientific spent 54.2% of its total revenues on COGS. Diagnostics & Scientific Instruments industry average (COGS share of revenue) in the same period was 49.6%
- R&D share of Revenues: As a percentage of revenue, Thermo Fisher Scientific spent 4.1% of its total revenues on R&D. Diagnostics & Scientific Instruments industry average R&D spending in the same period was 5.9%
- SG&A share of Revenues: As a percentage of revenue, Thermo Fisher Scientific spent 27.2% of its total revenues on Sales, Marketing, and General Administration (SG&A). Diagnostics & Scientific Instruments industry average SG&A spending in the same period was 28.0%
- Inventory share of Revenues: As a percentage of revenue, Thermo Fisher Scientific spent 12.1% of its total revenues on Inventories. Diagnostics & Scientific Instruments industry average Inventory spending in the same period was 10.1%
- Accounts Payable share of Revenues: As a percentage of revenue, Thermo Fisher Scientific invested 5.1% of its total revenues on Accounts Payable (A/P) Diagnostics & Scientific Instruments industry average Accounts Payable investment in the same period was 6.5%
- Accounts Receivable share of Revenues: As a percentage of revenue, Thermo Fisher Scientific invested 16.7% of its total revenues on Accounts Receivable (A/R). Diagnostics & Scientific Instruments industry average Accounts Receivable investment in the same period was 16.1%
- PP&E share of Revenues: As a percentage of revenue, Thermo Fisher Scientific invested 14.1% of its total revenues on Property, Plants, and Equipments (PP&E). Diagnostics & Scientific Instruments industry average PPE investment in the same period was 15.9%
- Intangibles share of Revenues: As a percentage of revenue, Thermo Fisher Scientific invested 193.2% of its total revenues on Intangibles. Diagnostics & Scientific Instruments industry average Intangibles investment in the same period was 122.0%
- Net Margins: Thermo Fisher Scientific Net Margins in the year 2016 were 11.1%. Diagnostics & Scientific Instruments industry average Net Margins in the same period were 10.7%
Sector and Industry Association of Thermo Fisher Scientific
For the purpose of performance benchmarking of a company with a sector or industry average, R&P Research associates every company with one sector and one industry. An industry consists of companies with related/similar business models. A sector comprises of a group of related/similar industries. For high-level analysis purposes, related/similar sectors are grouped into sector groups.
Thermo Fisher Scientific is associated with Healthcare Sector Group, Life Sciences Sector, and Diagnostics & Scientific Instruments Industry.
Life Sciences sector is comprised of the following industries: Pharmaceuticals; Medical Devices; Biotechnology; Diagnostics & Scientific Instruments. The definitions for each of the industries is as follows:
- Pharmaceuticals industry includes companies that discover, develop, manufacture, and market medicines licensed for use as medications. In general these companies offer pharmaceutical products that can be described as prescription or over-the-counter medicines. Many Pharmaceutical companies also offer a diverse portfolio of animal health products, services and solutions. Many diversified pharmaceutical companies operate in more than two operating segments like consumer health products, medical devices and pharmaceutical.
- Medical Devices industry includes manufacturers and distributors of medical equipments and medical supplies. Medical equipments include large scale capital equipmets such as X-Ray machines and MRI scanners and other nondisposable medical devices like stents and pacemakers. Medical supplies include makers of contact lenses, eyeglass lenses, bandages and other disposable products.
- Biotechnology industry includes Biotechnology product companies, subscription companies, and service companies. Biotechnology product companies offer pharmaceutical drug products that are manufactured in, extracted from, or semi synthesized from biological sources. Subscription-based companies develop genome databases, which can be used to develop medicinal drugs. Service companies offer solutions based on a common technology or generic tool of other large pharmaceutical or biopharmaceutical companies.
- Diagnostics & Scientific Instruments industry includes companies that provide testing products, diagnostic reagents, instruments and diagnostic services to aid in the detection and treatment of a wide range of diseases. It also includes molecular diagnostic and genetic testing companies that develop, manufacture, market and provide diagnostic tests, diagnostic systems and related products and services. Also included are companies that manufacture and market analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics.
Industry Ranking of Thermo Fisher Scientific
With $18.3 billion revenues, Thermo Fisher Scientific ranked number 1 of all the companies in the US Diagnostics & Scientific Instruments industry. There were a total of 22 public companies in the US Diagnostics & Scientific Instruments industry that had revenues greater than $50 million during 2016.
The top-10 companies in the US Diagnostics & Scientific Instruments industry by revenues during 2016 were:
Business Model Analysis (BMA) Framework
We use the following framework to assess the business model of a company. Business Model Analysis framework can be used by organizations to articulate growth strategies and identify cost optimization opportunities. Technology and consulting companies can use this framework to identify the value drivers and pain points of their targeted customers. Entrepreneurs can use this framework to understand the language of business and identify promising business opportunities. This framework can be used by any professional aspiring to take up a leadership role to better understand the businesses challenges, articulate growth strategy, and monitor the business improvement requirements for the organization.
- Conduct a holistic benchmarking; to identify and target additional sources of value
- Get in touch with us to learn more about Business Model Analysis Framework
- Get free data, charts, and analysis of Thermo Fisher Scientificand its peers on select key performance indicators by clicking the reports provided below